The FDA reverses its ban on Juul e-cigarettes

The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape maker.

The FDA first ordered the company to stop selling its products in 2022, but they have stayed on shelves pending an appeal. Juul has maintained its status as the No. 2 e-cigarette maker in the U.S. during this time.

Now, the FDA says Juul's products are back under agency review — although it emphasized that this new status was not an indication they would be fully cleared.

Juul became one of the highest-profile successes of the initial burst in e-cigarette use more than a decade ago. That success was beset by concerns that e-cigarettes were introducing a new generation of people to nicotine addiction. Vaping reached a peak of approximately 28% among all high school students in 2019, according to the Centers for Disease Control and Prevention.

While Juul has since entered a period of financial retrenchment, sales of e-cigarettes and other alternative nicotine products have continued to grow.

Leave a Comment